Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 178
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
Andréas Mackensen, John B.A.G. Haanen, Christian Koenecke, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2844-2853
Open Access | Times Cited: 112
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 57
Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery
Thierry Burnouf, Ming‐Li Chou, David J. Lundy, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 49
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 31
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
Luise Fischer, Nora Grieb, Patrick Born, et al.
Leukemia (2024) Vol. 38, Iss. 2, pp. 372-382
Open Access | Times Cited: 20
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
Caroline Lonez, Eytan Breman
Cells (2024) Vol. 13, Iss. 2, pp. 146-146
Open Access | Times Cited: 18
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Strategies to enhance CAR-T persistence
Yue Liu, Lingna An, Ruihao Huang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 53
mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
Satomi Ando, Charles M. Perkins, Yamato Sajiki, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 2
Open Access | Times Cited: 46
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
Wei Wei, Zhi‐Nan Chen, Ke Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12317-12317
Open Access | Times Cited: 40
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Metabolic engineering for optimized CAR-T cell therapy
Sarah McPhedran, Gillian Carleton, Julian J. Lum
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 396-408
Closed Access | Times Cited: 15
Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 13
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 11
Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy
Fei Hou, Zichao Guo, M. Ho, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8571-8599
Closed Access | Times Cited: 11
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells
Wei‐Xiang Sin, N. Suhas Jagannathan, Denise Bei Lin Teo, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 10
Implantable CAR T cell factories enhance solid tumor treatment
Sharda Pandit, Pritha Agarwalla, Feifei Song, et al.
Biomaterials (2024) Vol. 308, pp. 122580-122580
Closed Access | Times Cited: 9
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Priyanka Maridhi Nanjireddy, Scott H. Olejniczak, Nataliya P. Buxbaum
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top